Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies.
Luk C, Compta Y, Magdalinou N, Martí MJ, Hondhamuni G, Zetterberg H, Blennow K, Constantinescu R, Pijnenburg Y, Mollenhauer B, Trenkwalder C, Van Swieten J, Chiu WZ, Borroni B, Cámara A, Cheshire P, Williams DR, Lees AJ, de Silva R. Luk C, et al. Among authors: magdalinou n. J Neurochem. 2012 Nov;123(3):396-405. doi: 10.1111/j.1471-4159.2012.07911.x. Epub 2012 Sep 3. J Neurochem. 2012. PMID: 22862741 Free article. Clinical Trial.
Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes.
Jabbari E, Woodside J, Guo T, Magdalinou NK, Chelban V, Athauda D, Lees AJ, Foltynie T, Houlden H, Church A, Hu MT, Rowe JB, Zetterberg H, Morris HR. Jabbari E, et al. Among authors: magdalinou nk. J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):768-773. doi: 10.1136/jnnp-2018-320151. Epub 2019 Mar 13. J Neurol Neurosurg Psychiatry. 2019. PMID: 30867224 Free PMC article.
Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic.
Paterson RW, Slattery CF, Poole T, Nicholas JM, Magdalinou NK, Toombs J, Chapman MD, Lunn MP, Heslegrave AJ, Foiani MS, Weston PSJ, Keshavan A, Rohrer JD, Rossor MN, Warren JD, Mummery CJ, Blennow K, Fox NC, Zetterberg H, Schott JM. Paterson RW, et al. Among authors: magdalinou nk. Alzheimers Res Ther. 2018 Mar 20;10(1):32. doi: 10.1186/s13195-018-0361-3. Alzheimers Res Ther. 2018. PMID: 29558979 Free PMC article.
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease.
Heslegrave A, Heywood W, Paterson R, Magdalinou N, Svensson J, Johansson P, Öhrfelt A, Blennow K, Hardy J, Schott J, Mills K, Zetterberg H. Heslegrave A, et al. Among authors: magdalinou n. Mol Neurodegener. 2016 Jan 12;11:3. doi: 10.1186/s13024-016-0071-x. Mol Neurodegener. 2016. PMID: 26754172 Free PMC article.
Increased CSF neurogranin concentration is specific to Alzheimer disease.
Wellington H, Paterson RW, Portelius E, Törnqvist U, Magdalinou N, Fox NC, Blennow K, Schott JM, Zetterberg H. Wellington H, et al. Among authors: magdalinou n. Neurology. 2016 Mar 1;86(9):829-35. doi: 10.1212/WNL.0000000000002423. Epub 2016 Jan 29. Neurology. 2016. PMID: 26826204 Free PMC article.
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
Hansson O, Janelidze S, Hall S, Magdalinou N, Lees AJ, Andreasson U, Norgren N, Linder J, Forsgren L, Constantinescu R, Zetterberg H, Blennow K; Swedish BioFINDER study. Hansson O, et al. Among authors: magdalinou n. Neurology. 2017 Mar 7;88(10):930-937. doi: 10.1212/WNL.0000000000003680. Epub 2017 Feb 8. Neurology. 2017. PMID: 28179466 Free PMC article.
25 results